Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback